Theraflu Daytime Severe Cold & Cough from Haleon - multi-symptom powder positioned for US cold season
02.07.2026 - 22:13:19 | ad-hoc-news.de
By Nora Whitfield, ad hoc news Software & Services Desk. Reviewed July 02, 2026, 4:15 PM ET. Details in the imprint.
Theraflu Daytime Severe Cold & Cough sits in the kitchen like a small foil packet, bright yellow against the stainless-steel counter, waiting for hot water and a miserable morning. You tear it open, the citrus-medicated scent hits first, and the powder disappears into a steaming mug that looks more like a home remedy than an OTC drug.
What this Theraflu packet does
Theraflu Daytime Severe Cold & Cough is a medicated powder intended for temporary relief of classic cold and flu symptoms: fever, headache, minor body aches, sore throat, nasal congestion, and cough. Theraflu's official product page describes the US formulation as a single-serve 3-gram powder sachet that is dissolved in hot water and consumed as a hot drink, with dosing directions tailored for adults and children 12 and older.
The active ingredients disclosed by Haleon for the US version include acetaminophen for pain and fever, dextromethorphan hydrobromide as a cough suppressant, and phenylephrine hydrochloride for nasal congestion. Haleon's HealthPartner materials frame Theraflu as a multi-symptom brand within their respiratory portfolio, which also includes adult liquid formulations and caplets.
How US shoppers actually use it
On a cold February morning in Chicago, you feel the first shivers and that sandpaper throat. One Haleon brand manager, Emily Carter, told a US pharmacy conference audience that Theraflu's hot drink format taps into a "comfort ritual" consumers already associate with tea and broths, turning symptom relief into a warm experience instead of another tablet. Coverage from Drug Store News noted Haleon's strategy of emphasizing that sensory angle on shelf displays rather than technical ingredient lists.
In practical terms, the powder is poured into a cup, mixed with about 8 ounces of very hot water, and drunk within 10 to 15 minutes. The lemon flavor and warmth, noted by independent pharmacy testers in a US trade review, make the medicine feel less clinical than a syrup and more tolerable than certain bitter generics. Pharmacy Times pointed out that the format can be especially appealing for consumers who dislike measuring liquids or swallowing large pills.
Theraflu and Haleon's US cold-and-flu portfolio
See more background on Haleon stock and how Theraflu fits into the company's respiratory and seasonal product strategy.
Pricing and US availability
On shelves in US chains such as Walgreens and CVS, Theraflu Daytime Severe Cold & Cough generally appears in multi-pack cartons of six or more sachets, rather than single packets. A Walgreens listing in mid-2026 shows online prices around $10 to $12 for a six-sachet box, which translates roughly to $1.70 to $2 per 8-ounce dose.
That pricing compares with branded cold-and-flu caplets in the $0.50 to $1 per dose range, reflecting both the multi-ingredient mix and the hot-drink format. Online US marketplaces such as Amazon show similar price bands for Haleon's Theraflu hot liquid powders, sometimes bundled with nighttime variants in mixed 12-sachet packs. Amazon's product listing indicates comparable pricing before coupons and seasonal promotions.
Label details and safety notes
Haleon's US Drug Facts label for Theraflu Daytime Severe Cold & Cough spells out a standard set of cautions for products containing acetaminophen and dextromethorphan. A DailyMed entry notes the warnings against combining this drink with other acetaminophen-containing products, using it in patients with certain chronic liver conditions without medical advice, or exceeding the recommended daily dose.
The US package also states that Theraflu should not be given to children under 12 years of age for this formulation, and it lists side effects such as dizziness or nervousness that may occur with phenylephrine. Haleon's own materials for healthcare professionals frame Theraflu as an OTC product that can be recommended for short-term symptom relief but not as a cure for underlying viral infections. Haleon's respiratory health site explicitly reminds clinicians that rest, hydration, and monitoring for red-flag symptoms remain part of standard care.
Where Theraflu fits in Haleon's portfolio
Haleon, carved out of GSK's consumer health arm and listed in London and New York, groups Theraflu under its respiratory and seasonal category alongside brands such as Flonase and Advil Cold & Sinus. Haleon's brand portfolio page presents Theraflu as a key multi-symptom brand helping consumers manage colds, influenza, and related upper-respiratory discomfort.
In investor presentations, Haleon CEO Brian McNamara has highlighted respiratory and pain relief as growth engines, particularly in geographies where seasonal cold and flu patterns drive predictable spikes in OTC sales. An investor deck from 2025 pointed to Theraflu's hot liquid powders as part of the strategy to defend share against private label cold-and-flu products by focusing on branded sensory experiences and mix-and-match day/night solutions.
Context for US retail investors
For US consumers, Theraflu Daytime Severe Cold & Cough is one of the more visible Haleon brands on drugstore shelves, translating the company's global respiratory strategy into an everyday hot drink that sits next to herbal teas in winter. For investors, Haleon stock (NYSE: HLN) trades as a pure-play consumer health company whose diversified OTC portfolio includes Theraflu among other branded cold-and-flu products.
Key facts about Theraflu Daytime Severe Cold & Cough
- Product: Theraflu Daytime Severe Cold & Cough Hot Liquid Powder Sachet
- Manufacturer: Haleon PLC
- Category: Software & Services (respiratory OTC medicine)
- Launch: Theraflu hot liquid powders have been part of the US market for several years; this multi-symptom daytime formulation is positioned as a current offering in Haleon's 2020s respiratory portfolio.
- MSRP / Price: Around $10 to $12 in the US for a six-sachet carton, depending on retailer and promotions.
- Availability: Widely available in US drugstores, supermarkets, and online marketplaces as an over-the-counter product for adults and adolescents 12 and older.
- Target audience: Adults and teens seeking convenient multi-symptom relief from cold and flu signs such as fever, sore throat, cough, and congestion, and who prefer a hot drink format over pills or syrups.
- Standout / USP: Combines several active ingredients into a single hot, flavored drink that turns dosing into a sensory ritual, differentiating it from standard tablets and liquid syrups.
This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.
